热门资讯> 正文

Praxis精密药品宣布拟议公开募股

2025-10-17 04:05

Praxis Precision Medicines (NASDAQ:PRAX) said on Thursday it plans to offer shares of its common stock and prefunded warrants in a public offering, with all securities to be sold by the company.
The size and pricing of the offering were not disclosed.
The company granted underwriters a 30-day option to buy up to 15% additional shares.

PRAX -2.92% after hours to $157.78.
Source: Press Release

More on Praxis Precision Medicines

Praxis: Positive 8-Week Radiant Study Data Leads To Other Expected Catalysts
Praxis surges after late-stage trial success for movement disorder therapy
Biggest stock movers Thursday: PRAX, HPE, GRAL, FOSL, VERI, and more

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。